Health Care: Drugs

Sunesis Pharmaceuticals Inc (SNSS: NASDAQ)

$3.71 n/a | n/a%
04/21/17 - 04:00 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 2.54M 3.06M 5.73M 7.96M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 2.54M 3.06M 5.73M 7.96M
Selling, General, and Administrative Expenses 16.11M 18.66M 23.11M 10.84M
Research & Development 22.88M 23.70M 27.66M 28.89M
Operating Income before D & A (EBITDA) -36.46M -39.30M -45.04M -31.77M
Depreciation & Amortization 370.00K 162.00K 396.00K 641.00K
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net 158.00K 3.56M 3.76M 92.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -36.67M -35.90M -41.68M -32.32M
Interest Expense 1.72M 939.00K 1.72M 2.92M
Pre-Tax Income -38.39M -36.84M -43.40M -35.24M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -38.02M -36.68M -43.00M -34.60M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -38.02M -36.68M -43.00M -34.60M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -38.02M -36.68M -43.00M -34.60M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-38.02M -36.68M -43.00M -34.60M
Preferred Dividends
Net Income Available To Common -38.02M -36.68M -43.00M -34.60M
Basic EPS from Continuing Ops. -2.42 -3.02 -4.30 -3.96
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -2.42 -3.02 -4.30 -3.96
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -2.42 -3.02 -4.30 -3.96
Basic Normalized Net Income/Share -2.42 -3.02 -4.30 -3.96
EPS fr Continuing Ops. -2.42 -3.02 -4.57 -3.96
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -2.42 -3.02 -4.57 -3.96
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -2.42 -3.02 -4.57 -3.96
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-2.42 -3.02 -4.57 -3.96
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with SNSS

Latest SNSS Headlines from TheStreet

More Financial News for SNSS

Press Releases for SNSS

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter